Equity and EthicsLSDMDMA

Underground MDMA-, LSD-and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary

This article documents a Zurich psychotherapist’s years-long underground provision of MDMA-, LSD- and 2‑C‑B‑assisted individual and group psycholytic psychotherapy, ending with her 2009 arrest, and reports on clinical outcomes and practice details. It situates these findings in the context of expanding medical research on psychedelics and highlights the attendant psychopharmacological, moral, ethical and legal tensions for regulation and clinical adoption.

Authors

  • Ben Sessa

Published

Drug Science Policy and Law
individual Study

Abstract

Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s and 1980s, respectively. This article describes the work of a Zurich-based psychotherapist providing individual and group psycholytic psychotherapy, whose practice persisted for several years before she was arrested in 2009. The article provides commentary on the psychopharmacological, moral, ethical and legal issues of this case and discusses these issues in the context of the growing medical research of psychedelic substances as mainstream treatments for psychiatry.

Available with Blossom Pro

Research Summary of 'Underground MDMA-, LSD-and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary'

Introduction

Psychedelic substances have long been used in non-Western and archaic cultures for psycho-spiritual purposes and were the focus of substantial psychiatric research after LSD's discovery in 1943. That clinical research largely ceased by the 1970s amid widespread recreational use, and only in recent decades has interest resumed in using such compounds as adjuncts to psychotherapy. Despite the hiatus in formal research, the authors note continuing pockets of underground psychedelic-assisted psychotherapy worldwide. This paper presents a descriptive account of one such underground project in Zurich, reconstructed from several interviews between UK psychiatrist Ben Sessa and German psychiatrist Friederike Fischer. The account aims to describe the therapist's training and practice, the structure and content of individual and group psycholytic sessions, client characteristics and reported outcomes, and the legal, ethical and clinical implications of the project in the context of a resurging formal research field in psychedelics.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    individual
  • Journal
  • Compounds
  • Topic
  • Author
  • APA Citation

    Sessa, B., & Fischer, F. M. (2016). Underground MDMA-, LSD-and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary. Drug Science, Policy and Law, 2. https://doi.org/10.1177/2050324515578080

References (7)

Papers cited by this study that are also in Blossom

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

Gasser, P., Holstein, D., Michel, Y. et al. · Journal of Nervous and Mental Disease (2014)

594 cited
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)

Psychedelics and mental health: a population study

Krebs, T. S., Johansen, P. ˚. Ø. · PLOS ONE (2013)

Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence

Krupitsky, E. M., Burakov, A. M., Dunaevsky, I. V. et al. · Journal of Psychoactive Drugs (2007)

154 cited
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder

Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)

Effects of Schedule I drug laws on neuroscience research and treatment innovation

King, C., Nichols, D. E. · Nature Reviews Neuroscience (2013)

Making a medicine out of MDMA

Sessa, B., Nutt, D. J. · British Journal of Psychiatry (2015)

Cited By (7)

Papers in Blossom that reference this study

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Underground MDMA-, LSD-and 2-CB-assisted... — Research Summary & Context | Blossom